GR1001011B - Θεραπευτικος παραγων. - Google Patents

Θεραπευτικος παραγων.

Info

Publication number
GR1001011B
GR1001011B GR900100315A GR900100315A GR1001011B GR 1001011 B GR1001011 B GR 1001011B GR 900100315 A GR900100315 A GR 900100315A GR 900100315 A GR900100315 A GR 900100315A GR 1001011 B GR1001011 B GR 1001011B
Authority
GR
Greece
Prior art keywords
affinity chromatography
chymopapain
methods
derivative
therapeutic agent
Prior art date
Application number
GR900100315A
Other languages
English (en)
Other versions
GR900100315A (en
Inventor
John Alan Barrett
John David Battle
Hulbert Daniel Rich
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of GR900100315A publication Critical patent/GR900100315A/el
Publication of GR1001011B publication Critical patent/GR1001011B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Η εφεύρεση αυτή αναφέρεται σε μεθόδους για την παρασκευή χυμοπαπαϊνης κατάλληλης για την παρασκευή βελτιωμένων φαρμακευτικών συνθέσεων για χρησιμοποίηση σε μεθόδους για την θεραπεία βλαμμένων, που σχηματίζουν κήλη ή κατά άλλο τρόπο μη φυσιολογικών μεσοσπονδύλιων δίσκων σπονδυλικής στήλης θηλαστικών. Οι μέθοδοι ενσωματώνουν ένα στάδιο καθίζησης οξέος και κατά προτίμηση μια διαδικασία χρωματογραφίας συγγενείας που χρησιμοποιεί μια μήτρα που στρέφεται σε ενεργό θέση. Κοινολογείται επίσης ένα παρασκεύασμα μονοειδικού αντισώματος που εγείρεται κατά χυμοπαπαϊνης παρασκευασμένης με την μέθοδο. Περιγράφονται ένα αναστρέψιμο πεπτίδιο αναστολέα χυμοπαπαϊνης που έχει ένα C-τελικό παράγωγο φαινυλαλανίνης ή παράγωγο ανάλογου φαινυλαλανίνης, και μήτρες χρωματογραφιών συγγενείας που στρέφονται προς ενεργές θέσεις για χρήση στο στάδιο της χρωματογραφίας συγγενείας. ω
GR900100315A 1989-04-28 1990-04-26 Θεραπευτικος παραγων. GR1001011B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909836A GB8909836D0 (en) 1989-04-28 1989-04-28 Therapeutic agent

Publications (2)

Publication Number Publication Date
GR900100315A GR900100315A (en) 1991-09-27
GR1001011B true GR1001011B (el) 1993-03-31

Family

ID=10655944

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100315A GR1001011B (el) 1989-04-28 1990-04-26 Θεραπευτικος παραγων.

Country Status (34)

Country Link
US (2) US5380656A (el)
EP (1) EP0470136B1 (el)
JP (1) JPH04506003A (el)
KR (1) KR920701241A (el)
CN (1) CN1047340A (el)
AT (1) ATE107660T1 (el)
AU (1) AU631641B2 (el)
BG (1) BG60916B1 (el)
CA (1) CA2056402C (el)
DD (1) DD296960A5 (el)
DE (1) DE69010199T2 (el)
DK (1) DK0470136T3 (el)
EG (1) EG19583A (el)
ES (1) ES2055427T3 (el)
FI (1) FI914995A7 (el)
GB (1) GB8909836D0 (el)
GR (1) GR1001011B (el)
HR (1) HRP930700A2 (el)
HU (2) HUT58345A (el)
IE (1) IE64351B1 (el)
IL (1) IL94227A (el)
IN (2) IN170683B (el)
LT (1) LT3827B (el)
LV (1) LV10200B (el)
MX (1) MX20503A (el)
NO (1) NO914206L (el)
NZ (1) NZ233475A (el)
PL (1) PL166810B1 (el)
PT (1) PT93921B (el)
RO (1) RO112032B1 (el)
RU (1) RU2074891C1 (el)
WO (1) WO1990013561A1 (el)
YU (1) YU87090A (el)
ZA (1) ZA903228B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent
EP0572547A1 (en) * 1991-02-22 1993-12-08 The Du Pont Merck Pharmaceutical Company SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES
CA2061861A1 (en) * 1991-03-04 1992-09-05 Jonathan Duvick Plant polypeptides with inhibitory activity towards pathogenic microorganisms
CN1060519C (zh) * 1991-05-09 2001-01-10 广西亚热带作物研究所 桄榔植物蛋白酶的提取方法
DE69223325T2 (de) * 1991-10-14 1998-04-16 Cash Eng Res Einlassregelvorrichtung für verdichter
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
EP1159273A1 (en) 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
DE60021254T2 (de) * 1999-03-15 2006-04-20 AXYS Pharmaceuticals, Inc., South San Francisco N-cyanomethylamide als protease inhibitoren
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6703040B2 (en) 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
US7935337B2 (en) 2002-12-25 2011-05-03 Hiromichi Komori Method of therapy for degenerative intervertebral discs
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US20080069907A1 (en) * 2004-07-06 2008-03-20 Chikao Morimoto Compositions for Cancer Prevention, Treatment, or Amelioration Comprising Papaya Extract
CN1320111C (zh) * 2004-08-09 2007-06-06 王美岭 一种制备木瓜凝乳酶的方法
US20060241566A1 (en) * 2005-04-11 2006-10-26 Orthox, Llc Nucleus Extraction from Spine Intervertebral Disc
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US20070265633A1 (en) * 2006-05-11 2007-11-15 Moon Jon K Implement and method to extract nucleus from spine intervertebral disc
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
WO2013038936A1 (ja) * 2011-09-13 2013-03-21 タカラバイオ株式会社 ペルオキシダーゼ反応の停止方法及び反応停止剤
WO2014004512A1 (en) 2012-06-25 2014-01-03 Surmodics, Inc. Bioerodable poly(etheresteramides) and medical article uses
CN118878631B (zh) * 2024-06-05 2025-04-04 中国海洋大学 一种基于配体垂钓筛选合成牡蛎ace抑制肽的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE270723C (el) *
US2313875A (en) * 1940-12-17 1943-03-16 Eugene F Jansen Proteolytic enzyme process
US3320131A (en) * 1964-10-23 1967-05-16 Baxter Laboratories Inc Method for the treatment of herniation of intervertebral discs
US3558433A (en) * 1967-11-07 1971-01-26 Baxter Laboratories Inc Process for purification of chymopapain
YU40433B (en) * 1975-02-20 1986-02-28 Lek Tovarna Farmacevtskih Process for obtaining pure, proteolytically active anzymes
DE3212846A1 (de) 1981-04-13 1982-11-04 Sintokogio, Ltd., Nagoya, Aichi Apparat und verfahren zum herstellen eines kerns
US4374926A (en) * 1981-05-13 1983-02-22 Smith Laboratories, Inc. Method for the production of improved chymopapain
US4719108A (en) * 1981-05-13 1988-01-12 Smith Laboratories, Inc. Chymopapain composition and method for its use
US4439423A (en) * 1981-05-13 1984-03-27 Smith Laboratories, Inc. Chymopapain and method for its use
EP0065395B1 (en) * 1981-05-13 1988-08-24 BOOTS-FLINT, INC. (a Delaware corp.) Improved chymopapain and method for its production and use
GB2124233B (en) * 1982-07-19 1985-09-18 Nat Res Dev Synthetic peptides and their preparation
GB2156821A (en) * 1984-04-03 1985-10-16 Simmons James W Process for purifying chymopapain
HU196624B (en) * 1986-12-08 1988-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing chymopapain with high specific activity
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent

Also Published As

Publication number Publication date
EG19583A (en) 1995-09-30
BG95362A (bg) 1993-12-24
LT3827B (en) 1996-03-25
LV10200A (lv) 1994-10-20
WO1990013561A1 (en) 1990-11-15
KR920701241A (ko) 1992-08-11
HRP930700A2 (en) 1995-06-30
DD296960A5 (de) 1991-12-19
HU211746A9 (en) 1995-12-28
LTIP1645A (en) 1995-07-25
YU87090A (sh) 1992-09-07
DK0470136T3 (da) 1994-08-01
CA2056402A1 (en) 1990-10-29
PT93921B (pt) 1996-10-31
AU5547290A (en) 1990-11-29
FI914995A0 (fi) 1991-10-23
CN1047340A (zh) 1990-11-28
GR900100315A (en) 1991-09-27
DE69010199T2 (de) 1994-10-13
ES2055427T3 (es) 1994-08-16
IL94227A (en) 1994-12-29
IE64351B1 (en) 1995-07-26
RU2074891C1 (ru) 1997-03-10
LV10200B (en) 1995-04-20
PL166810B1 (pl) 1995-06-30
NO914206L (no) 1991-12-17
NO914206D0 (no) 1991-10-25
DE69010199D1 (de) 1994-07-28
IE901538L (en) 1990-10-28
IL94227A0 (en) 1991-01-31
ATE107660T1 (de) 1994-07-15
HU903342D0 (en) 1992-01-28
GB8909836D0 (en) 1989-06-14
ZA903228B (en) 1990-12-28
HUT58345A (en) 1992-02-28
RO112032B1 (ro) 1997-04-30
CA2056402C (en) 1999-11-16
PT93921A (pt) 1990-11-20
EP0470136A1 (en) 1992-02-12
AU631641B2 (en) 1992-12-03
NZ233475A (en) 1991-10-25
US5380656A (en) 1995-01-10
FI914995A7 (fi) 1991-10-23
BG60916B1 (bg) 1996-06-28
EP0470136B1 (en) 1994-06-22
IN173230B (el) 1994-03-12
JPH04506003A (ja) 1992-10-22
MX20503A (es) 1993-12-01
US5468480A (en) 1995-11-21
IN170683B (el) 1992-05-02

Similar Documents

Publication Publication Date Title
GR1001011B (el) Θεραπευτικος παραγων.
Schultz et al. Epithelial wound healing enhanced by transforming growth factor-α and vaccinia growth factor
EP0028627B1 (de) Verfahren zur herstellung von thymosin-alpha1 und derivaten davon
Takahashi et al. Identification of the motoneuron-depolarizing peptide in bovine dorsal root as hypothalamic substance P
DE69030100D1 (de) Peptidderivat, verfahren zu dessen herstellung, sowie dieses enthaltende pharmazeutische zusammensetzung
PT97992A (pt) Processo de preparacao de analogos polipeptidicos
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
EP0662827A4 (en) THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS BASED ON NOTCH PROTEINS AND NUCLEIC ACIDS.
CA2329754A1 (en) Peptide composition as immunogen for the treatment of allergy
AU2836995A (en) Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
ZA952086B (en) Heterocyclic compounds their preparation and use
DE69632815D1 (de) gC1q-REZEPTOR, DARAN BINDENDE HIV-1 gp120-REGION, VERWANDTE PEPTIDE UND ANTIKÖRPER
RU94042240A (ru) Антагонисты рецепторов возбужденных аминокислот, способ получения, промежуточные соединения, фармацевтическая композиция
Legrand et al. Evidence that a collagen-derived nonapeptide is a specific inhibitor of platelet-collagen interaction
Tuross Albumin preservation in the Taima-taima mastodon skeleton
DE69631542D1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
JPS60190796A (ja) 脳特異的なｍＲＮＡから翻訳されたプロテイノイドの部分に対応する合成ポリペプチド、これを用いた受容体、方法及び診断系
UA29395C2 (uk) Похідне прегна-4,9(11),17(20)-трієн-3-она, спосіб його одержання, спосіб одержання 21-ацилоксипрегна-4, 9(11),16-трієн-3,20-діону та проміжні сполуки
DD210259A5 (de) Verfahren zur herstellung von polypeptiden
DE69737202T2 (de) Thrombolytische substanzen mit antithrombotische aktivität
IL114185A (en) Substituted alkyldiamine derivatives pharmaceutical compositions containing them and process for their preparation
CH645880A5 (de) Synthetisches antigenaktives polypeptid, verfahren zu dessen herstellung und das polypeptid enthaltendes antigenes mittel sowie arzneimittel.
Robinson [13] Purification of tetanus toxin and its major peptides
IL87349A (en) Water-soluble factor that activates glial cells, its preparation and pharmaceutical compositions comprising it